medigraphic.com
ISSN 1659-1046 (Print)
Odovtos - International Journal of Dental Sciences

2024, Number 2

<< Back Next >>

Odovtos-Int J Dent Sc 2024; 26 (2)

Salivary Cytokine Profile in Patients with Oral Lichen Planus

Martins HJS, Simone SR, Angenendt CLH, Alves RMJ, Fragoso MAC

Language: English
References: 40
Page: 128-140
PDF size: 353.89 Kb.


ABSTRACT

This study aimed to determine salivary concentrations of interleukin (IL)-1β, IL-2, IL-10, IL- 23, transforming growth factor (TGF)-β, tumor necrosis factor (TNF)-α, nitrate (a by-product of nitric oxide oxidation), and cortisol in patients with oral lichen planus (OLP). Twenty patients diagnosed with OLP and 20 sex-matched healthy volunteers (HV) were included in this cross-sectional study. Unstimulated whole saliva was collected in the morning. Salivary cytokine and cortisol concentrations were determined by enzyme-linked immunosorbent assays (ELISA). Nitrate was measured in a nitric oxide analyzer. We found higher salivary concentrations of IL-2 (p ‹0.003), IL-23 ( p ‹0.04), and TGF-β (p=0.05) in patients with OLP compared to HV. No significant differences were found in salivary levels of TNF-α, IL-1β, or IL-10. Nitrate concentrations were markedly increased in OLP patients (1,227.0 ± 738.8 µM/mg total protein) when compared to HV (261.6 ± 166.8 µM/mg; p ‹0.0001). Salivary cortisol levels were also higher in OLP patients (2.79 ± 1.39 vs. 1.94 ±1.21 ng/mg; p ‹0.048). The markedly increased salivary levels of nitric oxide in patients with OLP suggest a relationship of this molecule with the cell death and tissue damage observed in these lesions.


REFERENCES

  1. Au J., Patel D., Campbell J.H. Oral lichen planus. Oral Maxillofac Surg Clin North Am. 2013; 25 (1): 93-100, vii. DOI: 10.1016/j.coms.2012.11.007

  2. Arisawa E.A., Almeida J.D., Carvalho Y.R., Cabral L.A. Clinicopathological analysis of oral mucous autoimmune disease: A 27-year study. Med Oral Patol Oral Cir Bucal. 2008; 13 (2): E94-7.

  3. Lodi G., Scully C., Carrozzo M., Griffiths M., Sugerman P.B., Thongprasom K. Current controversies in oral lichen planus: report of an international consensus meeting. Part 2. Clinical management and malignant transformation. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2005; 100 (2): 164-78. DOI: 10.1016/j.tripleo.2004.06.076

  4. Gonzalez-Moles M.A., Warnakulasuriya S., Gonzalez-Ruiz I., Gonzalez-Ruiz L., Ayen A., Lenouvel D., et al. Worldwide prevalence of oral lichen planus: A systematic review and meta-analysis. Oral Dis. 2021; 27 (4): 813-28. DOI: 10.1111/odi.13323

  5. Ingafou M., Leao J.C., Porter S.R., Scully C. Oral lichen planus: a retrospective study of 690 British patients. Oral Dis. 2006; 12 (5): 463-8. DOI: 10.1111/j.1601-0825.2005.01221.x

  6. Lu R., Zhang J., Sun W., Du G., Zhou G. Inflammation-related cytokines in oral lichen planus: an overview. J Oral Pathol Med. 2015; 44 (1): 1-14. DOI: 10.1111/jop.12142

  7. Humberto J.S.M., Pavanin J.V., Rocha M., Motta A.C.F. Cytokines, cortisol, and nitric oxide as salivary biomarkers in oral lichen planus: a systematic review. Braz Oral Res. 2018; 32: e82. DOI: 10.1590/1807-3107bor-2018.vol32.0082

  8. Nadendla L.K., Meduri V., Paramkusam G., Pachava K.R. Association of salivary cortisol and anxiety levels in lichen planus patients. J Clin Diagn Res. 2014; 8 (12): ZC01-3. DOI: 10.7860/JCDR/2014/8058.5225

  9. Zucoloto M.L., Shibakura M.E.W., Pavanin J.V., Garcia F.T., da Silva Santos P.S., Maciel A.P., et al. Severity of oral lichen planus and oral lichenoid lesions is associated with anxiety. Clin Oral Investig. 2019; 23 (12): 4441-8. DOI: 10.1007/s00784-019-02892-2

  10. van der Meij E.H., van der Waal I. Lack of clinicopathologic correlation in the diagnosis of oral lichen planus based on the presently available diagnostic criteria and suggestions for modifications. J Oral Pathol Med. 2003; 32 (9): 507-12. DOI: 10.1034/j.1600-0714.2003.00125.x

  11. Cheng Y.S., Gould A., Kurago Z., Fantasia J., Muller S. Diagnosis of oral lichen planus: a position paper of the American Academy of Oral and Maxillofacial Pathology. Oral Surg Oral Med Oral Pathol Oral Radiol. 2016; 122 (3): 332-54. DOI: 10.1016/j.oooo.2016.05.004

  12. von Elm E., Altman D.G., Egger M., Pocock S.J., Gotzsche P.C., Vandenbroucke J.P., et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. PLoS Med. 2007; 4 (10):e296. DOI: 10.1371/journal.pmed.0040296

  13. Navazesh M. Methods for collecting saliva. Ann N Y Acad Sci. 1993; 694: 72-7. DOI: 10.1111/j.1749-6632.1993.tb18343.x

  14. Sugerman P.B., Satterwhite K., Bigby M. Autocytotoxic T-cell clones in lichen planus. Br J Dermatol. 2000; 142 (3): 449-56. DOI: 10.1046/j.1365-2133.2000.03355.x

  15. Scully C., Beyli M., Ferreiro M.C., Ficarra G., Gill Y., Griffiths M., et al. Update on oral lichen planus: etiopathogenesis and management. Crit Rev Oral Biol Med. 1998; 9 (1): 86-122. DOI: 10.1177/10454411980090010501

  16. Payeras M.R., Cherubini K., Figueiredo M.A., Salum F.G. Oral lichen planus: focus on etiopathogenesis. Arch Oral Biol. 2013; 58 (9): 1057-69. DOI: 10.1016/j.archoralbio.2013.04.004

  17. Ghallab N.A., el-Wakeel N., Shaker O.G. Levels of salivary IFN-gamma, TNF-alfa, and TNF receptor-2 as prognostic markers in (erosive) oral lichen planus. Mediators Inflamm. 2010; 2010: 847632. DOI: 10.1155/2010/847632

  18. Rhodus N.L., Cheng B., Myers S., Miller L., Ho V., Ondrey F. The feasibility of monitoring NF-kappaB associated cytokines: TNF-alpha, IL-1alpha, IL-6, and IL-8 in whole saliva for the malignant transformation of oral lichen planus. Mol Carcinog. 2005; 44 (2): 77-82. DOI: 10.1002/mc.20113

  19. Mozaffari H.R., Ramezani M., Mahmoudiahmadabadi M., Omidpanah N., Sadeghi M. Salivary and serum levels of tumor necrosis factor-alpha in oral lichen planus: a systematic review and meta-analysis study. Oral Surg Oral Med Oral Pathol Oral Radiol. 2017; 124 (3): e183-e9. DOI: 10.1016/j.oooo.2017.06.117

  20. Yamamoto T., Osaki T. Characteristic cytokines generated by keratinocytes and mononuclear infiltrates in oral lichen planus. J Invest Dermatol. 1995; 104 (5): 784-8. DOI: 10.1111/1523-1747.ep12606990

  21. Zhu Z.D., Ren X.M., Zhou M.M., Chen Q.M., Hua H., Li C.L. Salivary cytokine profile in patients with oral lichen planus. J Dent Sci. 2022; 17 (1): 100-5. DOI: 10.1016/j.jds.2021.06.013

  22. Simark-Mattsson C., Bergenholtz G., Jontell M., Eklund C., Seymour G.J., Sugerman P.B., et al. Distribution of interleukin-2, -4, -10, tumour necrosis factor-alpha and transforming growth factor-beta mRNAs in oral lichen planus. Arch Oral Biol. 1999; 44 (6): 499-507. DOI: 10.1016/s0003-9969(99)00013-8

  23. Hu J.Y., Zhang J., Cui J.L., Liang X.Y., Lu R., Du G.F., et al. Increasing CCL5/CCR5 on CD4+ T cells in peripheral blood of oral lichen planus. Cytokine. 2013; 62 (1): 141-5. DOI: 10.1016/j.cyto.2013.01.020

  24. Wei W., Sun Q., Deng Y., Wang Y., Du G., Song C., et al. Mixed and inhomogeneous expression profile of Th1/Th2 related cytokines detected by cytometric bead array in the saliva of patients with oral lichen planus. Oral Surg Oral Med Oral Pathol Oral Radiol. 2018; 126 (2): 142-51. DOI: 10.1016/j.oooo.2018.02.013

  25. Han G., Li F., Singh T.P., Wolf P., Wang X.J. The pro-inflammatory role of TGFbeta1: a paradox? Int J Biol Sci. 2012; 8 (2): 228-35. DOI: 10.7150/ijbs.8.228

  26. Iwakura Y., Ishigame H. The IL-23/IL-17 axis in inflammation. J Clin Invest. 2006; 116 (5): 1218-22. DOI: 10.1172/JCI28508

  27. Lu R., Zeng X., Han Q., Lin M., Long L., Dan H., et al. Overexpression and selectively regulatory roles of IL-23/IL-17 axis in the lesions of oral lichen planus. Mediators of inflammation. 2014; 2014: 701094. DOI: 10.1155/2014/701094

  28. Wang H., Luo Z., Lei L., Sun Z., Zhou M., Dan H., et al. Interaction between oral lichen planus and chronic periodontitis with Th17-associated cytokines in serum. Inflammation. 2013; 36 (3): 696-704. DOI: 10.1007/s10753-013-9594-2

  29. Morishima N., Mizoguchi I., Takeda K., Mizuguchi J., Yoshimoto T. TGF-beta is necessary for induction of IL-23R and Th17 differentiation by IL-6 and IL-23. Biochem Biophys Res Commun. 2009; 386 (1): 105-10. DOI: 10.1016/j.bbrc.2009.05.140

  30. Akhurst R.J., Hata A. Targeting the TGFbeta signalling pathway in disease. Nat Rev Drug Discov. 2012; 11 (10): 790-811. DOI: 10.1038/nrd3810

  31. Pekiner F.N., Demirel G.Y., Borahan M.O., Ozbayrak S. Cytokine profiles in serum of patients with oral lichen planus. Cytokine. 2012; 60 (3): 701-6. DOI: 10.1016/j.cyto.2012.08.007

  32. Zhou G., Zhang J., Ren X.W., Hu J.Y., Du G.F., Xu X.Y. Increased B7-H1 expression on peripheral blood T cells in oral lichen planus correlated with disease severity. J Clin Immunol. 2012; 32 (4): 794-801. DOI: 10.1007/s10875-012-9683-2

  33. Abdelwhab A., Kandeel M.M., Yassin H.H., Abdelmonem W., Shaker O.G. Evaluation of serum and salivary transforming growth factor beta, vascular endothelial growth factor and tumor necrosis factor alpha in oral lichen planus. . J Oral Res. 2020; 9 (2): 86-92. DOI: https://doi.org/10.17126/joralres.2020.012

  34. Daff S. NO synthase: structures and mechanisms. Nitric Oxide. 2010; 23 (1): 1-11. DOI: 10.1016/j.niox.2010.03.001

  35. Pacher P., Beckman J.S., Liaudet L. Nitric oxide and peroxynitrite in health and disease. Physiol Rev. 2007; 87 (1): 315-424. DOI: 10.1152/physrev.00029.2006

  36. Pautz A., Art J., Hahn S., Nowag S., Voss C., Kleinert H. Regulation of the expression of inducible nitric oxide synthase. Nitric Oxide. 2010; 23 (2): 75-93. DOI: 10.1016/j.niox.2010.04.007

  37. Tvarijonaviciute A., Aznar-Cayuela C., Rubio C.P., Ceron J.J., Lopez-Jornet P. Evaluation of salivary oxidate stress biomarkers, nitric oxide and C-reactive protein in patients with oral lichen planus and burning mouth syndrome. J Oral Pathol Med. 2017; 46 (5): 387-92. DOI: 10.1111/jop.12522

  38. Ohashi M., Iwase M., Nagumo M. Elevated production of salivary nitric oxide in oral mucosal diseases. J Oral Pathol Med. 1999; 28 (8): 355-9. DOI: 10.1111/j.1600-0714.1999.tb02053.x

  39. Koray M., Dulger O., Ak G., Horasanli S., Ucok A., Tanyeri H., et al. The evaluation of anxiety and salivary cortisol levels in patients with oral lichen planus. Oral Dis. 2003; 9 (6): 298-301. DOI: 10.1034/j.1601-0825.2003.00960.x

  40. Shah B., Ashok L., Sujatha G.P. Evaluation of salivary cortisol and psychological factors in patients with oral lichen planus. Indian J Dent Res. 2009; 20 (3): 288-92. DOI: 10.4103/0970-9290.57361




2020     |     www.medigraphic.com